SCHEMBL8309914

SCHEMBL8309914

CCOc1ccc(C(C)=NOCCO)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.47
NQO1 P15559 1/20 0.45
PARP10 Q53GL7 1/20 0.45
PRSS1 P07477 1/20 0.45
PRSS2 P07478 1/20 0.45
PRSS3 P35030 1/20 0.45
LMNA P02545 2/20 0.44
PTBP1 P26599 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 2/20 0.43
FURIN P09958 1/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.42
PLK1 P53350 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
USP2 O75604 1/20 0.41
PLA2G4B P0C869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8309913 1.00 NR1I2 (0.47) NR1I2NQO1PARP10PRSS1PRSS2
SCHEMBL17577932 0.80 PPARA (0.51) LMNAPTBP1SMN1; SMN2NPC1MAPK1
SCHEMBL5609817 0.79 PPARG (0.50) NR1I2LMNAPTBP1SMN1; SMN2ALDH1A1
SCHEMBL5609820 0.79 PPARG (0.50) NR1I2LMNAPTBP1SMN1; SMN2ALDH1A1
SCHEMBL8309507 0.79 MAPT (0.51) NR1I2LMNAPTBP1SMN1; SMN2MAPK1
SCHEMBL8309510 0.79 MAPT (0.51) NR1I2LMNAPTBP1SMN1; SMN2MAPK1
SCHEMBL4476864 0.78 LMNA (0.69) LMNAPTBP1SMN1; SMN2KMT2AALDH1A1
SCHEMBL4476867 0.78 LMNA (0.69) LMNAPTBP1SMN1; SMN2KMT2AALDH1A1
SCHEMBL8309791 0.75 NQO1 (0.56) NQO1PARP10PRSS1PRSS2PRSS3
SCHEMBL5610797 0.75 LMNA (0.56) LMNAPTBP1SMN1; SMN2NPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed